chr3-100748388-C-G

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_006070.6(TFG):​c.1060C>G​(p.Pro354Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00131 in 1,614,138 control chromosomes in the GnomAD database, including 9 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0012 ( 1 hom., cov: 32)
Exomes š‘“: 0.0013 ( 8 hom. )

Consequence

TFG
NM_006070.6 missense

Scores

1
3
15

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:4

Conservation

PhyloP100: 0.608

Publications

5 publications found
Variant links:
Genes affected
TFG (HGNC:11758): (trafficking from ER to golgi regulator) There are several documented fusion oncoproteins encoded partially by this gene. This gene also participates in several oncogenic rearrangements resulting in anaplastic lymphoma and mixoid chondrosarcoma, and may play a role in the NF-kappaB pathway. Multiple transcript variants have been found for this gene. [provided by RefSeq, Sep 2010]
TFG Gene-Disease associations (from GenCC):
  • hereditary motor and sensory neuropathy, Okinawa type
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • hereditary spastic paraplegia 57
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
  • autosomal dominant Charcot-Marie-Tooth disease type 2 due to TFG mutation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009718746).
BP6
Variant 3-100748388-C-G is Benign according to our data. Variant chr3-100748388-C-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 245772.
BS2
High Homozygotes in GnomAdExome4 at 8 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TFGNM_006070.6 linkc.1060C>G p.Pro354Ala missense_variant Exon 8 of 8 ENST00000240851.9 NP_006061.2 Q92734-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TFGENST00000240851.9 linkc.1060C>G p.Pro354Ala missense_variant Exon 8 of 8 1 NM_006070.6 ENSP00000240851.4 Q92734-1

Frequencies

GnomAD3 genomes
AF:
0.00120
AC:
182
AN:
152190
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000290
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00209
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000828
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00173
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00123
AC:
309
AN:
251136
AF XY:
0.00136
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000984
Gnomad ASJ exome
AF:
0.000397
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000601
Gnomad NFE exome
AF:
0.00197
Gnomad OTH exome
AF:
0.00196
GnomAD4 exome
AF:
0.00132
AC:
1927
AN:
1461830
Hom.:
8
Cov.:
33
AF XY:
0.00132
AC XY:
960
AN XY:
727214
show subpopulations
African (AFR)
AF:
0.000538
AC:
18
AN:
33476
American (AMR)
AF:
0.00112
AC:
50
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.000306
AC:
8
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39696
South Asian (SAS)
AF:
0.000580
AC:
50
AN:
86258
European-Finnish (FIN)
AF:
0.000655
AC:
35
AN:
53420
Middle Eastern (MID)
AF:
0.00954
AC:
55
AN:
5768
European-Non Finnish (NFE)
AF:
0.00147
AC:
1634
AN:
1111978
Other (OTH)
AF:
0.00128
AC:
77
AN:
60392
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
110
221
331
442
552
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
58
116
174
232
290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00120
AC:
183
AN:
152308
Hom.:
1
Cov.:
32
AF XY:
0.00113
AC XY:
84
AN XY:
74476
show subpopulations
African (AFR)
AF:
0.000313
AC:
13
AN:
41566
American (AMR)
AF:
0.00209
AC:
32
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5190
South Asian (SAS)
AF:
0.000829
AC:
4
AN:
4826
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10624
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00173
AC:
118
AN:
68012
Other (OTH)
AF:
0.00284
AC:
6
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.510
Heterozygous variant carriers
0
10
19
29
38
48
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00146
Hom.:
1
Bravo
AF:
0.00125
TwinsUK
AF:
0.00162
AC:
6
ALSPAC
AF:
0.00
AC:
0
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.00221
AC:
19
ExAC
AF:
0.00133
AC:
162
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00240
EpiControl
AF:
0.00290

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:4
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Benign:2
Sep 30, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

TFG: BP4, BS2 -

not specified Uncertain:1
Mar 11, 2017
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Sep 18, 2019
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Hereditary motor and sensory neuropathy, Okinawa type;C3714897:Hereditary spastic paraplegia 57 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.33
T
BayesDel_noAF
Benign
-0.44
CADD
Benign
20
DANN
Uncertain
0.99
DEOGEN2
Benign
0.23
.;T;T;.
Eigen
Benign
-0.27
Eigen_PC
Benign
-0.085
FATHMM_MKL
Uncertain
0.83
D
LIST_S2
Benign
0.79
.;.;T;T
M_CAP
Benign
0.026
D
MetaRNN
Benign
0.0097
T;T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
2.0
.;M;M;.
PhyloP100
0.61
PrimateAI
Benign
0.40
T
PROVEAN
Benign
-0.90
N;N;N;N
REVEL
Benign
0.047
Sift
Pathogenic
0.0
D;D;D;D
Sift4G
Uncertain
0.020
D;D;D;D
Polyphen
0.0010
.;B;B;.
Vest4
0.082
MVP
0.33
MPC
0.74
ClinPred
0.087
T
GERP RS
4.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.24
gMVP
0.22
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs111356679; hg19: chr3-100467232; API